The immunogenicity of an antigen can be increased by displaying it in a highly dense, multivalent context, such as on the surface of a virus or virus-like particle (VLP). However, for many viruses, the ability to display diverse antigens on viral surfaces through the construction of recombinant virus particles is limited because peptide insertions are not compatible with virus or VLP assembly. In this thesis, I examined the ability of VLPs of bacteriophage PP7 to have target peptides inserted into a single-chain dimer of its coat protein and form VLP that display the epitope of interest on the particle surface in an immunogenic manner. We found that bacteriophage PP7 is highly tolerant to defined peptide insertions, and a semi-random se...
Virus-like particles (VLPs) are empty viral shells derived from the expression of viral structural p...
Phage display is a powerful and versatile technology that enables the selection of novel binding fun...
BACKGROUND: Recombinant proteins and in particular single domains or peptides are often poorly immun...
The immunogenicity of an antigen can be increased by displaying it in a highly dense, multivalent co...
Many viral structural proteins are capable of spontaneously self-assembling into structures that res...
Peptide or subunit vaccines (antigens) are safer than attenuated vaccines. However, peptide vaccines...
Virus-like particles (VLPs) comprised of viral structural proteins that self-assemble into particles...
Virus-like particles (VLPs) have attracted attention as therapeutic platforms for the delivery of pe...
Background: Virus-like Particles (VLPs) display can be used to increase the immunogenicity of hetero...
Current human papillomavirus (HPV) vaccines that are based on virus-like particles (VLPs) of the maj...
Virus-like Particles (VLPs) display can be used to increase the immunogenicity of heterologous antig...
Copyright © 2012 Rita Lasickiene ̇ et al. This is an open access article distributed under the Creat...
Virus-like Particles (VLPs) display can be used to increase the immunogenicity of heterologous antig...
Virus-like particles (VLPs) make excellent vaccines. They are non-infectious, often easy to produce ...
We have developed a peptide display platform based on VLPs of the RNA bacteriophage MS2 that combine...
Virus-like particles (VLPs) are empty viral shells derived from the expression of viral structural p...
Phage display is a powerful and versatile technology that enables the selection of novel binding fun...
BACKGROUND: Recombinant proteins and in particular single domains or peptides are often poorly immun...
The immunogenicity of an antigen can be increased by displaying it in a highly dense, multivalent co...
Many viral structural proteins are capable of spontaneously self-assembling into structures that res...
Peptide or subunit vaccines (antigens) are safer than attenuated vaccines. However, peptide vaccines...
Virus-like particles (VLPs) comprised of viral structural proteins that self-assemble into particles...
Virus-like particles (VLPs) have attracted attention as therapeutic platforms for the delivery of pe...
Background: Virus-like Particles (VLPs) display can be used to increase the immunogenicity of hetero...
Current human papillomavirus (HPV) vaccines that are based on virus-like particles (VLPs) of the maj...
Virus-like Particles (VLPs) display can be used to increase the immunogenicity of heterologous antig...
Copyright © 2012 Rita Lasickiene ̇ et al. This is an open access article distributed under the Creat...
Virus-like Particles (VLPs) display can be used to increase the immunogenicity of heterologous antig...
Virus-like particles (VLPs) make excellent vaccines. They are non-infectious, often easy to produce ...
We have developed a peptide display platform based on VLPs of the RNA bacteriophage MS2 that combine...
Virus-like particles (VLPs) are empty viral shells derived from the expression of viral structural p...
Phage display is a powerful and versatile technology that enables the selection of novel binding fun...
BACKGROUND: Recombinant proteins and in particular single domains or peptides are often poorly immun...